Jones LA - Search Results

1

WAF1/Cip1 gene polymorphism and expression in carcinomas of the breast, ovary, and endometrium.

Lukas J, Groshen S, Saffari B, Niu N, Reles A, Wen WH, Felix J, Jones LA, Hall FL, Press MF. Lukas J, et al. Among authors: jones la. Am J Pathol. 1997 Jan;150(1):167-75. Am J Pathol. 1997. PMID: 9006333 Free PMC article.

2

p53 mutations and expression in ovarian cancers: correlation with overall survival.

Wen WH, Reles A, Runnebaum IB, Sullivan-Halley J, Bernstein L, Jones LA, Felix JC, Kreienberg R, el-Naggar A, Press MF. Wen WH, et al. Among authors: jones la. Int J Gynecol Pathol. 1999 Jan;18(1):29-41. doi: 10.1097/00004347-199901000-00005. Int J Gynecol Pathol. 1999. PMID: 9891239

3

Association of p53 mutations and a codon 72 single nucleotide polymorphism with lower overall survival and responsiveness to adjuvant radiotherapy in endometrioid endometrial carcinomas.

Saffari B, Bernstein L, Hong DC, Sullivan-Halley J, Runnebaum IB, Grill HJ, Jones LA, El-Naggar A, Press MF. Saffari B, et al. Among authors: jones la. Int J Gynecol Cancer. 2005 Sep-Oct;15(5):952-63. doi: 10.1111/j.1525-1438.2005.00159.x. Int J Gynecol Cancer. 2005. PMID: 16174251 Free article.

4

Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.

Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF. Saffari B, et al. Among authors: jones la. Cancer Res. 1995 Dec 1;55(23):5693-8. Cancer Res. 1995. PMID: 7585656

5

Correlation of p53 mutations with resistance to platinum-based chemotherapy and shortened survival in ovarian cancer.

Reles A, Wen WH, Schmider A, Gee C, Runnebaum IB, Kilian U, Jones LA, El-Naggar A, Minguillon C, Schönborn I, Reich O, Kreienberg R, Lichtenegger W, Press MF. Reles A, et al. Among authors: jones la. Clin Cancer Res. 2001 Oct;7(10):2984-97. Clin Cancer Res. 2001. PMID: 11595686

6

HER-2/neu oncogene amplification and expression in breast and ovarian cancers.

Press MF, Jones LA, Godolphin W, Edwards CL, Slamon DJ. Press MF, et al. Among authors: jones la. Prog Clin Biol Res. 1990;354A:209-21. Prog Clin Biol Res. 1990. PMID: 1978943 Review. No abstract available.

7

[Prognostic differentiation of ovarian carcinomas by immunohistochemical analysis of estrogen receptor expression].

Kieback DG, Press MF, McCamant SK, Atkinson EN, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA. Kieback DG, et al. Among authors: jones la. Geburtshilfe Frauenheilkd. 1995 Apr;55(4):189-94. doi: 10.1055/s-2007-1023299. Geburtshilfe Frauenheilkd. 1995. PMID: 7789706 German.

8

Improved prediction of survival in advanced adenocarcinoma of the ovary by immunocytochemical analysis and the composition adjusted receptor level of the estrogen receptor.

Kieback DG, McCamant SK, Press MF, Atkinson EN, Gallager HS, Edwards CL, Hajek RA, Jones LA. Kieback DG, et al. Among authors: jones la. Cancer Res. 1993 Nov 1;53(21):5188-92. Cancer Res. 1993. PMID: 8221656

9

Prognostic significance of estrogen receptor expression in ovarian cancer. Immunoreactive Score (IRS) vs. Composition Adjusted Receptor Level (CARL).

Kieback DG, Press MF, Atkinson EN, Edwards GL, Möbus VJ, Runnebaum IB, Kreienberg R, Jones LA. Kieback DG, et al. Among authors: jones la. Anticancer Res. 1993 Nov-Dec;13(6B):2489-96. Anticancer Res. 1993. PMID: 8135488

10

Ambivalence: A Key to Clinical Trial Participation?

Chilton JA, Rasmus ML, Lytton J, Kaplan CD, Jones LA, Hurd TC. Chilton JA, et al. Among authors: jones la. Front Oncol. 2018 Aug 10;8:300. doi: 10.3389/fonc.2018.00300. eCollection 2018. Front Oncol. 2018. PMID: 30148115 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

668 results

Search Page